What Happened?
Knoxville, TN-based Provectus Biopharmaceuticals Promoted Bruce Horowitz as Chief Operating Officer
About the Company
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus` investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
About the Person
Bruce Horowitz is Chief Operating Officer at Provectus Biopharmaceuticals. Previously, Bruce held various senior IT leadership roles in the industry.
Info Source
News
Short Profile